RS52481B - Formulacija hfa-suspenzije koja sadrži anhidrat - Google Patents

Formulacija hfa-suspenzije koja sadrži anhidrat

Info

Publication number
RS52481B
RS52481B YU86004A YUP86004A RS52481B RS 52481 B RS52481 B RS 52481B YU 86004 A YU86004 A YU 86004A YU P86004 A YUP86004 A YU P86004A RS 52481 B RS52481 B RS 52481B
Authority
RS
Serbia
Prior art keywords
suspensions
hfa
acid
contain
fact
Prior art date
Application number
YU86004A
Other languages
English (en)
Serbian (sr)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Publication of YU86004A publication Critical patent/YU86004A/sh
Publication of RS52481B publication Critical patent/RS52481B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
YU86004A 2002-03-28 2003-03-20 Formulacija hfa-suspenzije koja sadrži anhidrat RS52481B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats
PCT/EP2003/002899 WO2003082244A2 (fr) 2002-03-28 2003-03-20 Formulations de suspensions d'un anhydrate contenant un gaz propulseur hfa

Publications (2)

Publication Number Publication Date
YU86004A YU86004A (sh) 2006-08-17
RS52481B true RS52481B (sr) 2013-02-28

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
YU86004A RS52481B (sr) 2002-03-28 2003-03-20 Formulacija hfa-suspenzije koja sadrži anhidrat

Country Status (21)

Country Link
EP (1) EP1492498A2 (fr)
JP (1) JP5147158B2 (fr)
KR (1) KR101005717B1 (fr)
CN (1) CN1642525A (fr)
AU (1) AU2003221509B2 (fr)
BR (1) BR0308709A (fr)
CA (1) CA2479638C (fr)
DE (1) DE10214264A1 (fr)
EA (1) EA008610B1 (fr)
EC (1) ECSP045322A (fr)
HR (1) HRP20040890A2 (fr)
IL (1) IL163696A0 (fr)
ME (1) ME00246B (fr)
MX (1) MXPA04009338A (fr)
NO (1) NO20044004L (fr)
NZ (1) NZ536030A (fr)
PL (1) PL371295A1 (fr)
RS (1) RS52481B (fr)
UA (1) UA79776C2 (fr)
WO (1) WO2003082244A2 (fr)
ZA (1) ZA200405637B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080007656A (ko) * 2005-05-02 2008-01-22 베링거 인겔하임 인터내셔날 게엠베하 티오트로피움 브로마이드의 신규한 결정질 형태
EP2085396A3 (fr) * 2005-05-02 2009-11-25 Boehringer Ingelheim International Gmbh Nouvelles formules cristallines de bromure de tiotropium
SI3106149T1 (sl) * 2009-05-29 2020-07-31 Pearl Therapeutics, Inc. Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
HK1219059A1 (zh) 2013-03-15 2017-03-24 珍珠治疗公司 用於微粒晶体材料的状态调节的方法和系统
EP3922240B1 (fr) * 2016-09-19 2023-06-21 Mexichem Fluor S.A. de C.V. Composition pharmaceutique comprenant du bromide de tiotropium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AU749697B2 (en) * 1998-08-04 2002-07-04 Jagotec Ag Medicinal aerosol formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
CA2436537C (fr) * 2000-10-31 2009-05-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Nouvelles compositions pharmaceutiques
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
EA200401159A1 (ru) 2005-04-28
NO20044004L (no) 2004-10-05
JP2005527550A (ja) 2005-09-15
CA2479638C (fr) 2011-01-04
YU86004A (sh) 2006-08-17
CN1642525A (zh) 2005-07-20
BR0308709A (pt) 2005-01-04
KR101005717B1 (ko) 2011-01-05
MXPA04009338A (es) 2005-01-25
AU2003221509A1 (en) 2003-10-13
AU2003221509B2 (en) 2008-01-24
KR20040098022A (ko) 2004-11-18
ECSP045322A (es) 2005-01-28
DE10214264A1 (de) 2003-10-16
ME00246B (fr) 2011-05-10
ZA200405637B (en) 2005-07-27
MEP47308A (en) 2011-02-10
EA008610B1 (ru) 2007-06-29
WO2003082244A3 (fr) 2004-02-05
JP5147158B2 (ja) 2013-02-20
CA2479638A1 (fr) 2003-10-09
UA79776C2 (en) 2007-07-25
IL163696A0 (en) 2005-12-18
PL371295A1 (en) 2005-06-13
EP1492498A2 (fr) 2005-01-05
NZ536030A (en) 2006-07-28
HRP20040890A2 (en) 2005-06-30
WO2003082244A2 (fr) 2003-10-09

Similar Documents

Publication Publication Date Title
ME00243B (me) Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje lijeka
US7736627B2 (en) HFA suspension formulations containing an anticholinergic
AU2018303782B9 (en) New crystalline forms of vilanterol trifenatate and processes for their preparation
RS52481B (sr) Formulacija hfa-suspenzije koja sadrži anhidrat
RS52178B (sr) Formulacije hfa-suspenzija koje sadrže antiholinergik
US7244415B2 (en) HFA suspension formulations of an anhydrate
HK1079091B (en) Hfa-suspension formulations containing an anticholinergic
HK1086557B (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
HK1079093A (en) Hfa-suspension formulation of an anhydrate